SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-020399
Filing Date
2020-07-24
Accepted
2020-07-24 16:49:23
Documents
1
Period of Report
2020-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4069
  Complete submission text file 0000899243-20-020399.txt   5525
Mailing Address ONE UNIVERSITY SQUARE DRIVE, SUITE 280 PRINCETON NJ 08540
Business Address
Bjarke Henric Bjorn (Reporting) CIK: 0001652179 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39397 | Film No.: 201047362

Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Issuer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations